Interferon-Inducible Protein-10 and the Pathogenesis of Cutaneous T-Cell Lymphomas

References

• Hoppe R. T., Wood G. S., Abel E. A. Mycosis Fungoides and the Sezary Syndrome: Pathology, staging and treatment. Current Problems in Cancer 1990; 295–361
   Web of Science ®Google Scholar
• Kaye F. J., Bunn P. J., Steinberg S. M., Stocker J. L., Ihde D. C., Fischmann A. B., Glatstein E. J., Schechter G. P., Phelps R. M., Foss F. M., Parlette H. L., Anderson M. J., Sausville E. A. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N. Engl. J. Med. 1989; 321: 1784–90
   PubMed Web of Science ®Google Scholar
• Dmitrovsky E., Matthews M. J., Bunn P. A., Schechter G. P., Makuch R. W., Winkler C. F., Eddy J., Sausville E. A., Ihde D. C. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis. J. Clin. Oncol. 1987; 5: 208–15
   PubMed Web of Science ®Google Scholar
• Saed G., Fiveson D. P., Naidu Y., Nickoloff B. J. Mycosis Fungoides exhibits a Thl-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2 profile. J. Investigative Dermatol. 1994; 103: 29–33
   PubMed Web of Science ®Google Scholar
• Gottlieb A. B., Luster A. D., Posnett D. N., Carter D. M. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J. Exp. Med. 1988; 168: 941–8
   PubMed Web of Science ®Google Scholar
• Taub D. D., Lloyd A. R., Conlon K., Wang J. M., Ortaldo J. R., Harada A., Matsushima K., Kelvin D. J., Oppenheim J. J. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 1993; 177: 1809–14
   PubMed Web of Science ®Google Scholar
• Taub D. D., Longo D. L., Murphy W. J. Human Interferon-Inducible Protein-10 Induces Mononuclear Cell Infiltration in Mice and Promotes the Migration of Human T Lymphocytes Into the Peripheral Tissues of Human Peripheral Blood Lymphocytes-SCID mice. Blood 1996; 87: 1423–1431
   PubMed Web of Science ®Google Scholar
• Luster A. D., Unkeless J. C., Ravetch J. V. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985; 315: 672–6
   PubMed Web of Science ®Google Scholar
• Luster A. D., Ravetch J. V. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J. Exp. Med. 1987; 166: 1084–97
   PubMed Web of Science ®Google Scholar
• Narumi S., Hamilton T. A. Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. J. Immunol. 1991; 146: 3038–44
   PubMed Web of Science ®Google Scholar
• Gomez C. M., Hamilton T. A., Egido J., Emancipator S. N. Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in culture. Am. J. Pathol. 1993; 142: 433–9
   PubMed Web of Science ®Google Scholar
• Ohmori Y., Hamilton T. A. Cell type and stimulus specific regulation of chemokine gene expression. Biochem. Biophys. Res. Commun. 1994; 198: 590–6
   PubMed Web of Science ®Google Scholar
• Narumi S., Wyner L. M., Stoler M. H., Tannenbaum C. S., Hamilton T. A. Tissue-specific expression of murine IP-10 mRNA following systemic treatment with interferon gamma. J. Leukoc. Biol. 1992; 52: 27–33
   PubMed Web of Science ®Google Scholar
• Ohmori Y., Wyner L., Narumi S., Armstrong D., Stoler M., Hamilton T. A. Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am. J. Pathol. 1993; 142: 861–70
   PubMed Web of Science ®Google Scholar
• Vanguri P., Farber J. M. IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-A alpha in astrocytes and microglia. J. Immunol. 1994; 152: 1411–8
   PubMed Web of Science ®Google Scholar
• Oppenheim J. J., Zachariae C. O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu. Rev. Immunol. 1991; 9: 617–48
   PubMed Web of Science ®Google Scholar
• Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines. Adv. Immunol. 1994; 55: 97–179
   PubMed Web of Science ®Google Scholar
• Sarris A. H., Broxmeyer H. E., Wirthmueller U., Karasavvas N., Cooper S., Lu L., Krueger J., Ravetch J. V. Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J. Exp. Med. 1993; 178: 1127–32
   PubMed Web of Science ®Google Scholar
• Sarris A. H., Esgleyes-Ribot T., Crow M., Broxmeyer H. E., Karasavvas N., Pugh W., Grossman D., Deisseroth A., Duvic M. Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma. Blood 1995; 86: 651–8
   PubMed Web of Science ®Google Scholar
• Sarris A. H., Talpaz M., Deisseroth A. B., Estrov Z. Human Recombinant Interferon-Inducible Protein-10 Inhibits the Proliferation of Normal and Acute Myelogenous Leukemia Progenitors. Leukemia 1996, In Press
   PubMed Web of Science ®Google Scholar
• Aronica S. M., Mantel C., Gonin R., Marshall M. S., Sarris A., Cooper S., Hague N., Zhang X. F, Broxmeyer H. E. Interferon-inducible protein 10 and macrophage inflammatory protein-1 alpha inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line. J. Biol. Chem. 1995; 270: 21998–22007
   PubMed Web of Science ®Google Scholar
• Dewald B., Moser B., Barella L., Schumacher C., Baggiolini M., Clark L. I. IP-10, a gamma-interferon-inducible protein related to interleukin-8, lacks neutrophil activating properties. Immunol. Lett. 1992; 32: 81–4
   PubMed Web of Science ®Google Scholar
• Proost P., De W. P. C., Conings R., Opdenakker G., Billiau A., Van D. J. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J. Immunol. 1993; 150: 1000–10
   PubMed Web of Science ®Google Scholar
• Luster A. D., Leder P. IP-10, a-C-X-C-chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 1993; 178: 1057–65
   PubMed Web of Science ®Google Scholar
• Angiolillo A. L., Sgadari C., Taub D. D., Liao F., Farber J. M., Maheshwari S., Kleinman H. K., Reaman G. H., Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 1995; 182: 155–62
   PubMed Web of Science ®Google Scholar
• Cabanillas F., Armitage J., Pugh W. C., Weisenburger D., Duvic M. Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma. Annals of Internal Medicine 1995; 122: 210–217
   PubMed Web of Science ®Google Scholar
• Sausville E. A., Eddy J. L., Makuch R. W., Fischmann A. B., Schechter G. P., Matthews M., Glatstein E., Ihde D. C., Kaye F., Veach S. R. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome. Definition of three distinctive prognostic groups. Ann. Intern. Med. 1988; 109: 372–82
   PubMed Web of Science ®Google Scholar
• Taub D. D., Conlon K., Lloyd A. R., Oppenheim J. J., Kelvin D. J. Preferential migration of activated CD4+ and CD8+ T cells in response to MW-1 alpha and MIP-1 beta. Science 1993; 260: 355–8
   PubMed Web of Science ®Google Scholar
• Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301–14
   PubMed Web of Science ®Google Scholar
• Mackay C. R. Migration pathways and immunologic memory among T lymphocytes. Semin. Immunol. 1992; 4: 51–8
   PubMedGoogle Scholar
• Berg E. L., Yoshino T., Rott L. S., Robinson M. K., Warnock R. A., Kishimoto T. K., Picker L. J., Butcher E. C. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J. Exp. Med. 1991; 174: 1461–6
   PubMed Web of Science ®Google Scholar
• Picker L. J., Kishimoto T. K., Smith C. W., Warnock R. A., Butcher E. C. ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 1991; 349: 796–9
   PubMed Web of Science ®Google Scholar
• Shimizu Y., Shaw S., Graber N., Gopal T. V., Horgan K. J., Van S. G., Newman W. Activation-independent binding of human memory T cells to adhesion molecule ELAM-1. Nature 1991; 349: 799–802
   PubMed Web of Science ®Google Scholar
• Cotran R. S., Gimbrone M. J., Bevilacqua M. P., Mendrick D. L., Pober J. S. Induction and detection of a human endothelial activation antigen in vivo. J. Exp. Med. 1986; 164: 661–6
   PubMed Web of Science ®Google Scholar
• Tanaka Y., Adams D. H., Hubscher S., Hirano H., Siebenlist U., Shaw S. T-cell adhesion induced by proteoglycanimmobilized cytokine MIP-1 beta. Nature 1993; 361: 79–82
   PubMed Web of Science ®Google Scholar
• Ohmori Y., Hamilton T. A. The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J. Immunol. 1995; 154: 5235–44
   PubMed Web of Science ®Google Scholar
• Grassmann R., Berchtold S., Radant I., Alt M., Fleckenstein B., Sodroski J. G., Haseltine W. A., Ramstedt U. Role of human T-cell leukemia virus type I X region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 1992; 66: 4570–5
   PubMed Web of Science ®Google Scholar
• Brown D. A., Nelson F. B., Reinherz E. L., Diamond D. J. The human interferon-gamma gene contains an inducible promoter that can be transactivated by tax I and II. Eur. J. Immunol. 1991; 21: 1879–85
   PubMed Web of Science ®Google Scholar
• Tatewaki M., Yamaguchi K., Masao M., Ishii T., Miyasaka M., Mori S., Takachuki K., Watanabe T. Constitutive Overexpression of the L-Selectin Gene in Fresh Leukemic Cells of Adult T-Cell Leukemia That Can Be Trannsactivated by Human T-Cell Lymphotropic Virus Type 1 Tax. Blood 1985; 86: 3109–3117
   Google Scholar
• Pancake B. A., Zucker F. D. HTLV tax and mycosis fungoides [letter]. N. Engl. J. Med. 1993; 329
   PubMed Web of Science ®Google Scholar
• Ghosh S. K., Abrams J. T., Terunuma H., Vonderheid E. C., DeFreitas E. Human T-Cell Leukemia Virus Type I tax/rexDNA and RNA in Cutaneous T-Cell Lymphoma. Blood 1994; 84: 2663–2671
   PubMed Web of Science ®Google Scholar
• Manca N., Piacentini E., Gelmi M., Calzavara P., Manganoni M. A., Glukhov A., Gargiulo F., De Francesco M., Pirali F., De Panfilis G. Persistence of human T cell lymphotropic virus type 1 (HTLV-1) sequences in peripheral blood mononuclear cells from patients with mycosis fungoides. J. Exp. Med. 1994; 180: 1973–8
   PubMed Web of Science ®Google Scholar
• Pancake B. A., Zucker-Franklin D., Coutavas E. E. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. J. Clin. Invest. 1995; 95: 547–54
   PubMed Web of Science ®Google Scholar